IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 197 filers reported holding IMPAX LABORATORIES INC in Q2 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $1,069,000 | -12.1% | 23,279 | -10.3% | 0.00% | 0.0% |
Q1 2015 | $1,216,000 | +26.5% | 25,952 | -14.5% | 0.00% | 0.0% |
Q4 2014 | $961,000 | -14.0% | 30,350 | -35.7% | 0.00% | 0.0% |
Q3 2014 | $1,118,000 | -27.1% | 47,166 | -7.8% | 0.00% | -50.0% |
Q2 2014 | $1,534,000 | +690.7% | 51,139 | +598.1% | 0.00% | – |
Q1 2014 | $194,000 | +1663.6% | 7,325 | +1546.1% | 0.00% | – |
Q4 2013 | $11,000 | -97.1% | 445 | -97.6% | 0.00% | -100.0% |
Q3 2013 | $381,000 | -11.0% | 18,634 | -13.2% | 0.00% | 0.0% |
Q2 2013 | $428,000 | – | 21,457 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |